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Abstract
During vascular development, endothelial cells are exposed to a variety of rapidly changing
factors, including fluctuating oxygen levels. We have previously shown that Ankyrin Repeat and
SOCS Box Protein 4 (ASB4) is the most highly differentially expressed gene in the vascular
lineage during early differentiation and is expressed in the embryonic vasculature at a time when
oxygen tension is rising due to the onset of placental blood flow. In order to further our
understanding of the regulation of ASB4 expression in endothelial cells, we tested the effect of
various stressors for their ability to alter ASB4 expression in the immortalized murine endothelial
cell lines MS1 and SVR. ASB4 expression is decreased during hypoxic insult and shear stress
whereas it is increased in response to TNF-α. Further investigation indicated that Nuclear Factor
kappa B (NF-κB) is the responsible transcription factor involved in the TNF-α-induced
upregulation of ASB4, placing ASB4 downstream of NF-κB in the TNF-α signaling cascade and
identifying it as a potential regulator for TNF-α’s numerous functions associated with
inflammation, angiogenesis and apoptosis.
INTRODUCTION
Ankyrin repeat (AR) and SOCS (suppressor of cytokine signaling) box proteins (ASBs) are
characterized by two functional domains: a variable number of N-terminal ARs and a C-
terminal SOCS box1, 2. The N-terminal ARs recruit and bind substrate proteins to mediate
substrate polyubiquitination and proteasome-mediated degradation. The C-terminal SOCS
box mediates interactions with an elongin B/elongin C/cullin 5/Roc protein complex to form
an E3 ubiquitin ligase complex3. So far, 18 ASB family members have been identified in
mammals. They are involved in numerous processes including ubiquitination of a broad
range of target proteins, such as tumor necrosis factor receptor II (ASB3)4, adaptor protein
with PH and SH2 domains (ASB6)5 and creatine kinase B (ASB9) but also regulatory
functions like the inhibition of mitochondrial function (ASB9)6, spermatogenesis (ASB9)7,
alteration of myoblast differentiation (ASB15)8 and stimulation of angiogenesis (ASB5)9.
Our previous studies have demonstrated that ASB4 is highly differentially expressed in cells
of the vascular lineage (84-h Flk1+ cells) during development at a time when oxygen
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tensions are rapidly changing in the embryo10, suggesting that ASB4 may act as a cellular
“oxygen sensor” in the developing vasculature. Oxygen tension is important for
vasculogenesis as it is one of the major stimuli for the growth of new vessels. Failure of
vasculogenesis would be catastrophic for the organism because passive diffusion is not
sufficient to supply all cells with oxygen and nutrients. In vitro studies have demonstrated
that ASB4 interacts with FIH (Factor Inhibiting HIF1α) and promotes differentiation of
embryonic stem cells (ES) into the vascular lineage in an oxygen-dependent manner11, 12.
These studies suggest that ASB4 may function to modulate an endothelium-specific
response to changing oxygen tension during embryonic development.
In addition to ASB4’s putative role as an oxygen sensor during vasculogenesis, it also plays
a role in energy homeostasis. ASB4 reduces insulin receptor substrate 1 (IRS-1)
phosphorylation when co-expressed with G-protein pathway suppressor 1 (GPS1)13. In the
paraventricular nucleus of the rat brain, insulin and leptin both cause an increase in ASB4
expression, with leptin also causing an increase in ASB4 expressionin the arcuate nucleus of
the thalamus14. Although there is some knowledge of the regulation of ASB4 in neuronal
systems, nothing has been reported about the factors that affect ASB4 expression in
endothelial cells. It is still unclear how ASB4 expression is regulated in response to changes
in oxygen tension or what transcription factors are involved in this regulation. These are
critical holes in our understanding, not only in terms of ASB4’s involvement in
vasculogenesis during development, but also with respect to the role that ASB4 might play
in pathogenic processes in the adult.
In this report we attempt to fill in these gaps by identifying several conditions under which
ASB4 expression is altered in the SVR and MS1 endothelial cell lines, including changes in
oxygen tension, shear stress and TNF-α expression. In addition, we demonstrate that NF-κB
is a potential transcription factor for ASB4 expression. Our results suggest that ASB4
functions downstream of NF-κB and acts as a potential regulator of numerous pathways
involved in inflammation, angiogenesis and apoptosis.
MATERIALS AND METHODS
Cell culture and transfection conditions
MS1 and SVR murine endothelial pancreatic islet cells were obtained from ATCC 15. Cells
were grown at 37°C in Dulbecco’s modified Eagle’s medium (DMEM) with10% heat-
inactivated fetal bovine serum, 10 U/mL penicillin, and 10 μg/mL streptomycin (Gibco).
Normoxic cultures were performed under atmospheric oxygen tension (~21%) and 5% CO2.
Cells from passages 4–17 were used for all experiments and all cells were grown to
confluency. Hypoxic cultures were performed at 1% O2 and 5% CO2. Cells were serum
starved for 16 hours before treatment and incubated for 24 h after treatment before lysis
unless otherwise noted.
Shear stress
Shear stress experiments were performed as described previously16. MS1 cells were
maintained in DMEM with 10% fetal bovine serum and 1% penicillin/streptomycin. All cell
cultures were kept in a humidified 5% CO2/95% air incubator at 37°C. MS1 cells cultured
on 38 × 76 mm slides to confluence were either kept as static controls or subjected to shear
stress in a parallel plate flow chamber so that multiple slides could be sheared
simultaneously. A surface area of 14 cm2 on the MS1-seeded slide was exposed to fluid
shear stress generated by perfusing culture medium over the cells. The pH of the system was
kept constant by gassing with 5% CO2/95% air and the temperature was maintained at 37°C.
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Shear stress at 12 dyn/cm2 was used for all experiments, which is correspondent with the
physiological range in human arteries.
Reverse transcriptase PCR (RT-PCR) analysis
Total RNA was isolated with the RNeasy system (QIAGEN). RNA was reverse transcribed
with the iScript system (Bio-Rad) using the following specific primers: ASB4 PCR, forward
primer 5′TGCCCAGTTATAAGCTGAAGTCTTC and reverse primer
5′GTGTCTCTTCATCCTGGTTGTTG; glyceraldehydes-3-phosphate dehydrogenase
(GAPDH), forward primer 5′ACCCAGAAGACTGTGGATGG and reverse primer
TGTGAGGAGGGGAGATTCAG. For real-time PCR analysis, total RNA was reverse
transcribed with the iScript system (Bio-Rad). Multiplex real-time PCR was performed with
the ABI PRISM 7900 sequence detection system, software and reagents. The following
primers were used together with probes from the Universal Probe Library (Roche): ASB4
forward primer 5′TTTGCACTTCTGCACCACAC, reverse primer
5′CCTGGTTGTTGGTTTTCATGT, probe #58 5′CTCCATCC. RNA samples, dissolved in
water, were always prepared in triplicate. The ASB4 primers, DIG-labeled probe #58 as well
as VIC-labeled Human 18S rRNA from applied Biosystems (Cat. # 4319413E – 0810041)
were added to each sample as well as to the control samples and to wells containing only
water. The absorptions of the fluorophore-labeled RNA probes in these samples were
measured and the absorptions normalized with those wells that contained only water. RNA
input was calibrated with 18S expression levels. Relative ASB4 mRNA levels were
normalized to ASB4 RNA expression in the control samples.
Statistical analysis
An unpaired two-tailed Student t-test was used for specific comparisons between endpoints
in the experiments. Data are expressed as mean plus standard error of the mean. Statistical
significance was accepted at the 95% confidence interval.
RESULTS
ASB4 is expressed in the immortalized murine endothelial cell lines MS1 and SVR
Despite the fact that ASB4 is known to be the most highly differentially expressed gene in
the vascular lineage during early differentiation11, very little is known about the cellular
triggers or signaling pathways involved in the induction of ASB4 expression in endothelial
cells during vasculogenesis. We started our exploration of this gap in knowledge by
examining the basal expression level of ASB4 in endothelial cell lines. RNA from a variety
of endothelial cell lines was tested for ASB4 expression by RT-PCR analysis. C166, 2h11,
myocardial endothelial cells (MEC) and human umbilical vein endothelial cells (HUVEC)
did not express detectable amounts of ASB4 (Figure 1A, data for MEC and HUVEC are not
shown), despite the fact that all of these cell types are considered to be endothelial in
nature17, 18. However, MS1 and SVR cell lines displayed high levels of ASB4 expression
(Figure 1A). Both MSI and SVR cells are derived from murine endothelial cells located in
the pancreatic islets by sequential introduction of simian virus 40 (SV40) large T (tumor)
antigen (for MS1) and additionally H-ras (for SVR).15 Endothelial cells expressing the
temperature-sensitive large T antigen are immortalized in vitro. Upon implantation into
mice, MS1 cells form dormant hemangiomas. SVR cells, due to the additional expression of
H-ras, form rapidly proliferating angiosarcomas15. Each cell line retains properties of
endothelial cells including uptake of acetylated LDL and expression of VEGF receptor 1 and
219. When expression of ASB4 mRNA was compared between MS1 and SVR cell lines by
real time PCR, SVR cells demonstrated up to 6 fold higher expression levels of ASB4
(Figure 1B) possibly owing to the fact that H-ras is overexpressed in SVR cells. H-ras
causes endothelial cells to be capable of forming rapidly proliferating angiosarcomas in
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vivo15, suggesting the possibility that ASB4 may participate in or be activated by one of the
pathways downstream of H-ras responsible for this modulation of endothelial phenotype.
Identifying regulators of ASB4 expression
To date, no reports of ASB4 regulation within endothelial cells exists, in spite of its
exquisite spatial and temporal regulation within the endothelial lineage during mouse
development11. To explore the question of ASB4 regulation in endothelial cells, we
challenged MS1 cells with hypoxia and shear stress, stress factors known to affect
endothelial cells at a time during development when ASB4 is also expressed. MS1 cells
were serum-starved overnight (16 h) as part of the general culture conditions to synchronize
the cell cycle and afterwards were subjected to hypoxia (1% O2) for 16 hours, either with or
without the addition of 10% fetal bovine serum (FBS) to the culture media in order to
investigate the response to hypoxia under different levels of nutrition. mRNA samples from
the treated cells were then analyzed by real time PCR. Culturing MS1 cells under hypoxic
conditions with 10% FBS resulted in a 40% decrease in ASB4 expression (Figure 2A). This
downregulation of ASB4 expression was also observed in SVR cells following treatment
with hypoxia (Figure 2B). Interestingly, serum starvation was also a strong inducer of
decreased ASB4 expression (Figure 2A). However, this decrease was not additive with that
of hypoxic stress to the culture conditions, suggesting that ASB4 mRNA levels in cells not
treated with FBS are already relatively low so that a further reduction due to hypoxia is not
possible.
During vasculogenesis in the embryo, endothelial cells undergo shear stress as the
circulatory system starts to develop and blood begins to flow within the new vessels. Shear
stress of endothelial cells occurs at the same time in vascular development as ASB4
expression in endothelial cells, suggesting that this type of cellular stress may be an inducing
factor in ASB4 expression10. To test this theory, confluent MS1 cells were serum starved
and afterwards treated with 8 hours of laminar or oscillatory shear stress (both at 12 dyn/
cm2), after which mRNA was isolated from the cells and analyzed with real-time PCR.
Laminar shear stress simulates the conditions in a smooth, straight vessel in which
endothelial cells lining the vessel are exposed to a constant, unidirectional flow. In contrast,
oscillatory shear stress occurs to endothelial cells when they are positioned at a bifurcation
in the vessel or, in mature vessels, when atherosclerotic plaques line the vessel wall. The
resultant flow of blood is intermittent and turbulent. In culture conditions, oscillatory shear
stress is achieved by alternating the flow of media over the cells. In cells exposed to laminar
flow, ASB4 expression was decreased 50% compared to starved cells at rest (Figure 3A). In
contrast, oscillatory shear stress resulted in no significant change in ASB4 expression in
cultured MS1 cells (Figure 3B). Steady laminar shear stress is thought to be atheroprotective
or anti-inflammatory20–24. However, oscillatory shear is inflammatory, causing neointimal
hyperplasia and expression of pro-inflammatory markers, although endothelial responses
vary depending on the severity of the shear stress25–29. The fact that laminar flow, which is
atheroprotective, downregulates ASB4 suggests an involvement of ASB4 in inflammatory
and angiogenic processes. The importance of shear stress on ASB4 expression was further
emphasized by the fact that, while starved cells under hypoxic conditions did not show a
further decrease in ASB4 expression, laminar flow stress did cause a reduction in ASB4
expression over that seen with serum starvation alone. These results demonstrate that blood
flow conditions (more so than hypoxia) and the resultant shear stress experienced by
endothelial cells could be a powerful regulator of ASB4 expression during early vascular
development.
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TNF-α upregulates ASB4 expression
Nutrition rapidly improves in the embryo when the vasculature develops and blood begins to
flow. Therefore, one explanation for the upregulation of ASB4 expression during the period
of embryonic vascularization11 could be the increase in nutrition and certain cytokines that
become available to the embryo due to increased blood flow. MS1 cells cultured in the
presence of FBS exhibit a 2-fold higher expression of ASB4 than cells that do not received
FBS (Figure 2A). FBS is composed of a variety of nutrients and cytokines. Of these
ingredients, TNF-α and insulin were identified as potential factors that could cause an
increase in ASB4 expression. The effect of TNF-α on ASB4 expression was investigated
due to its ability to stimulate NF-κB30, which plays an important role in balancing
angiogenesis by several mechanisms including chromatin remodeling31, induction of
endothelial cell survival and secretion of angiogenic factors32–34 and could therefore also be
a transcription factor controlling the expression of ASB4. Insulin was tested due to the fact
that MS1 cells are derived from pancreatic islet endothelial cells which are tightly involved
in the development35 and regulation of beta-cells36 and also play a role in regulating insulin
secretion37 and hence it is possible that several of their functions are also regulated by
insulin. MS1 cells were once again serum-starved overnight (16 h) and treated with 10 μg/
ml insulin for 18 or 24 hours (Figure 4A) as well as 1 or 5 μg/ml insulin for 18 hours (Figure
4B). In a similar fashion, starved MS1 cells were treated with 20 ng/ml TNF-α for 8, 18 or
24 hours (Figure 4C) as well as 10, 20 or 40 ng/ml TNF-α for 24 hours (Figure 4D). Real-
time PCR was then performed to analyze levels of ASB4 mRNA. Treatment of MS1 cells
with insulin caused a slight increase in ASB4 expression whereas MS1 cells exhibited a
dose- and time-dependent increase in ASB4 expression of up to 2-fold following treatment
with TNF-α. Doubling the treatment dose of TNF-α (to 40 ng/ml) caused only a slight
increase in ASB4 expression, possibly due to cell toxicity. These results suggest that TNF-α
might be a key factor within FBS that contributes to stimulation of ASB4 expression.
IKK-inhibitor inhibits TNF-α upregulation of ASB4
TNF-α activates several pathways including NF-κB and MAPK and it has also been
associated with a weak induction of death cell signaling by activating caspase-838. We were
particularly interested in the activation of NF-κB because of its known role in stimulation of
angiogenesis33 and its potential effect on ASB4, which is highly expressed during vascular
development. To determine if the upregulation of ASB4 expression following TNF-α
treatment is due to an activation of the NF-κB pathway, we used IKK (inhibitory kappa-B
kinase) inhibitors to inhibit NF-κB activity. Activation of IKK results in phosphorylation of
IkBα with its subsequent polyubiquitination and degradation by the 26S proteasome39. This
releases the p65/p50 heterodimer, which translocates to the nucleus and transcribes target
genes, including cytokines and cell adhesion molecules. Inhibition of IKK reverses this
effect and the NF-κB heterodimer is not released. We used BMS-345441 and IKK inhibitor
VII as inhibitors of IKK-β40, 41. MS1 cells were treated with different concentrations of
BMS-345541 or IKK Inhibitor VII one hour prior to the beginning of the 24 hour incubation
of cells with TNF-α. ASB4 expression levels were determined with real-time PCR (Figure
5). Both BMS-345441 and Inhibitor VII were able to inhibit the TNF-α-induced ASB4
expression in MS1 cells, however Inhibitor VII was much more effective. The concentration
of BMS-345441 was increased to determine if the inhibition of TNF-α-induced ASB4
expression could be raised to the effectiveness of Inhibitor VII. However, increased
concentrations of BMS-345441 proved to be toxic to MS1 cells. These results indicate that
NF-κB is a transcription factor capable of inducing expression of ASB4 in MS1 cells. The
regulation of ASB4 by NF-κB makes sense as ASB4 is expressed during vascular growth, a
cellular process in which NF-κB plays an essential role by balancing pro- and anti-
angiogenic effects31 and by being part of the vascular endothelial growth factor
signaling42, 43. However, it also suggests a potential role for ASB4 in inflammatory vascular
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processes like atherosclerosis, which are also known to be mediated in part by NF-κB-
regulated pathways.
DISCUSSION
To date, only a limited number of studies have been reported identifying putative regulators
of ASB4 expression. Previous studies have shown that ASB4 can be influenced at the
protein level by certain factors like oxygen to modify its interactions with other proteins.
However, it is still not clear how the expression of the ASB4 gene can be modulated and
which pathways are involved. Therefore, the present study was undertaken to determine the
factors that affect ASB4 expression in endothelial cells. Our observations indicate that
ASB4 is regulated by oxygen and nutrient levels, shear stress and TNF-α stimulation.
Together, these observations shed new light on the regulation of ASB4 in vivo and highlight
the complexity of the regulatory pathways involved in modulating the effects of this protein.
Previously we have demonstrated that ASB4 expression in embryonic stem cells influences
the differentiation of these cells into the vascular lineage in an oxygen-dependent manner11.
In addition, we discovered that, during embryonic development, the peak of ASB4
expression in the embryonic vasculature coincides with the time that oxygen tension is
dramatically increasing owing to the initiation of placental blood flow11. In contrast, when
the embryonic vessels mature and oxygen levels stabilize, ASB4 expression is quickly
downregulated. We concluded from these results that ASB4 may be important in regulating
endothelial-specific responses to increasing oxygen tension; however, a direct relationship
between ASB4 expression and oxygen concentration had not been shown. In the present
study, we observed that hypoxia induces a decrease in ASB4 mRNA levels in cultured MS1
cells, supporting our hypothesis that oxygen tension plays an important role in the regulation
of ASB4. It is now apparent that oxygen levels affect ASB4 on multiple levels. Our previous
studies demonstrated that ASB4 interacts with the factor inhibiting HIF1alpha (FIH) and is a
substrate for FIH-mediated hydroxylation via an oxygen-dependent mechanism. This, along
with our current findings suggests that oxygen regulates ASB4 both through hydroxylation
of the ASB4 protein moiety and by transcriptional regulation of the gene.
One limitation of our study is that, despite looking in numerous endothelial cell lines as well
as primary endothelial cells such as HUVECs, we were only able to detect significant levels
of ASB4 in MS1 and SVR endothelial cells, both of which are immortalized murine cell
lines. It is possible that the apparent lack of ASB4 expression in the other cells could be due
to the fact that ASB4 is not expressed in these cells under standard conditions. It remains to
be determined if induction of ASB4 expression can be achieved in these cells under certain
conditions, such as TNF-α treatment, shear stress, hyper-oxygenation or insulin treatment. It
is also plausible that the lack of detectable ASB4 expression in these other cell types could
be due to the use of nonfunctional primers or unsuitable PCR temperature settings. Finally it
is possible that either the murine origin or immortalization of MS1 and SVR cells altered
them in such a way that promoted ASB4 expression. Further investigation of ASB4
expression in these different endothelial cell types is clearly warranted.
Despite the fact that we were not able to detect ASB4 in primary endothelial cells, our data
obtained in MSI and SVR cells are still physiologically relevant. MS1 and SVR cell lines
are both derived from murine pancreatic islet endothelial cells and are primarily used in
tumor angiogenesis studies. When implanted into mice, MS1and SVR cells form dormant
hemangiomas and rapidly growing angiosarcomas, respectively. They were originally used
to demonstrate the capability of H-ras to function as an angiogenic switch.15 The fact that
ASB4 is highly expressed in these cells suggests the possibility that there is a link between
Bode et al. Page 6













aggressive angiogenic activity and ASB4 expression, although the significance of this
relationship remains to be determined.
Two aspects of our findings in this report suggest that ASB4 may play a role in pro-
inflammatory responses. Firstly, we found ASB4 to be down regulated in response to
laminar shear stress, the form of shear stress that is thought to be atheroprotective or anti-
inflammatory24. Further support of the notion that ASB4 may be pro-inflammatory comes
from our observation that ASB4 is upregulated by TNF-α and most likely transcriptionally
activated by NF-κB. The cytokine TNF-α induces systemic inflammation via activation of
the NF-κB and MAPK pathways. NF-κB is a transcription factor that is known for its pro-
inflammatory effects but that also stimulates angiogenesis, in part, by increasing VEGF
transcription33, 44. The link between ASB4 expression and the NF-κB-regulated pathways
could suggest a potential role for ASB4 in inflammatory vascular processes like
atherosclerosis, although no known association of ASB4 and atherosclerotic plaques has
been reported, and nor has ASB4 been shown to be expressed in endothelial cells of adult
organisms to date.
The upregulation of ASB4 in MS1 endothelial cells in response to insulin indicates that
ASB4 may not only be important for pro-inflammatory responses and vascular development
but also for energy homeostasis and vascular response to nutrition levels. Glucose
homeostasis in particular appears to be a target of ASB4. ASB4 interacts with IRS-1, which
plays a key role in transmitting signals from the insulin receptor to intracellular pathways13.
In the paraventricular nucleus of the rat brain, insulin and leptin both cause an increase in
ASB4 expression, with leptin also causing an increase in ASB4 expressionin the arcuate
nucleus of the thalamus14. In our study of endothelial cells, ASB4 was upregulated by
insulin which is consistent with the previously published data. Interestingly, although we did
not find ASB4 to be expressed in all endothelial cell lines, we did find it to be highly
expressed in MS1 cells, which are also the cells in which ASB4 was induced by insulin.
MS1 cells are derived from the endothelial cells within the islets of the pancreas. Given the
ability of these cells to upregulate ASB4 expression an insulin-dependent manner, it is
possible that ASB4 plays a role in regulating blood flow within the pancreatic islets, perhaps
in response to changing nutritional demands that alter the circulating level of insulin that
could then alter the level of ASB4 either via a paracrine action or through regulation of the
blood supply within the pancreatic islets.
The data presented in this study offer insight into the subtle yet complex effects of ASB4 in
endothelial cells and may help us to better understand ASB4’s role in managing the cells’
response to various stimuli during angiogenesis. Our discovery of the involvement of NF-κB
in the regulation of ASB4 expression is particularly exciting as this suggests a potential role
for ASB4 in inflammatory responses in the embryonic period. It will be important, however,
to also investigate ASB4 protein expression to confirm that the observed changes in ASB4
RNA levels translate into translational changes. If this turns out to be a phenomenon at both
the RNA and protein levels, and if ASB4’s influence is demonstrated to extend beyond the
embryonic period and the MS1/SVR cell lines, it could suggest that ASB4 is potentially
instrumental in angiogenic and inflammatory processes later in life, such as those associated
with tumors, wound healing or bypassing of a thrombosis. Clearly though, further studies
will be needed in order to better understand the role of ASB4 not only in embryogenesis but
also in adult life.
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Expression of ASB4 in endothelial cells. (A) C166, 2h11, MS1 and SVR cells were cultured
to confluency, RNA was purified and RT-PCR with primers for ASB4 performed. RNA that
had not been reverse transcribed was used as a control for genomic contamination. Placental
cells from ASB4 knockout (ko P) and wild-type (wt P) mice were used as negative and
positive controls for ASB4 expression. (B) Real time PCR analysis was performed on
untreated MS1 and SVR cells and ASB4 expression normalized to MS1 cells. Results are
shown as mean ± SD of three independent experiments. ***p < 0.001.
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ASB4 mRNA expression following hypoxia treatment. (A) Real time PCR analysis of ASB4
expression levels normalized to the first sample (+serum, 21% O2). MS1 cells were grown
to confluency and treated for 16 hours with either serum containing medium or medium
without serum. Afterwards, cells were grown for 24 hours under hypoxic or normoxic
conditions. Results are shown as mean ± SD of three independent experiments. *p < 0.05,
***p < 0.001, ns = non-significant. (B) Real time PCR analysis of ASB4 expression levels.
SVR cells were grown to confluency and treated with hypoxia for 0, 6 or 18 hours. Results
are shown as mean ± SD of three independent experiments. Data are normalized to
expression at 0 h; *p < 0.05.
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ASB4 mRNA expression following shear stress. MS1 cells were serum-starved for 16 hours
and treated with 0 hours or 8 hours of (A) laminar (LS) or (B) oscillatory (OS) flow (12
dynes/cm2). Results are shown as mean ± SD of three independent experiments. Data are
normalized to expression at 0 h. *p < 0.05, ns = non-significant.
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ASB4 mRNA expression levels in MS1 cells following TNF-α or insulin treatment. Cells
were serum starved for 16 hours before treatment. After treatment, real-time PCR analysis
was performed. Data were normalized and significance calculated to expression at 0 hours.
(A) MS1 cells were treated with 20 ng/ml TNF-α for 0, 8, 18 or 24 hours. (B) MS1 cells
were treated with 0, 10, 20 or 40 ng/ml TNF-α for 24 hours. (C) MS1 cells were treated with
10 μg/ml insulin for 0, 18 or 24 hours. (D) MS1 cells (P. 13) were treated with 0, 1 or 5 μg/
ml insulin for 18 hours. Results are shown as mean ± SD of three independent experiments.
***p < 0.0001, **p < 0.005, *p < 0.05, ns = non-significant.
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Effect of IKK-inhibitors on ASB4 mRNA expression levels. MS1 cells were treated with
different concentrations of (A) BMS-345541 or (B) IKK Inhibitor VII one hour before TNF-
α (20 ng/ml) was added for 24 hours. ASB4 expression levels were determined with real-
time PCR and data normalized to ASB4 expression without stimulation by TNF-α. Results
are shown as mean ± SD of three independent experiments. ***p < 0.001, ns = non-
significant.
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